| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |